World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
24086
World Ranking
14698
National Ranking
7436

Research.com Recognitions

  • Fellow of The National Academy of Public Administration
  • Fellow of The National Academy of Public Administration

Overview

Samuel C. Mok is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research centers on cancer biology, with a particular emphasis on ovarian cancer and related fields within biochemistry, genetics, molecular biology, and medicine.

The scientist's main fields of study are:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Their subfields of study include:

  • Molecular Biology
  • Cancer Research
  • Immunology
  • Reproductive Medicine
  • Pulmonary and Respiratory Medicine

Samuel C. Mok has contributed extensively to topics related to:

  • Ovarian cancer diagnosis and treatment
  • Immune cells in cancer
  • Single-cell and spatial transcriptomics
  • Ferroptosis and cancer prognosis
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Endometrial and Cervical Cancer Treatments

Their scholarly output includes multiple recent papers such as:

  • "Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors" (2023) published in Cancer Research
  • "Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer" (2023) published in Cell
  • "ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment" (2020) published in Nature Communications
  • "Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression" (2020) published in Cancers
  • "Expression of long noncoding RNAs in cancer-associated fibroblasts linked to patient survival in ovarian cancer" (2020) published in Cancer Science

Frequent co-authors collaborating with Samuel C. Mok include:

  • Sammy Ferri-Borgogno
  • Karen H. Lu
  • Jared K. Burks
  • Stephen T.C. Wong
  • Jianting Sheng

Publication venues where Samuel's research is commonly featured are:

  • Cancer Research
  • Cancers
  • Gynecologic Oncology
  • Biophysical Journal
  • Clinical Cancer Research

Samuel C. Mok has been recognized as a Fellow of The National Academy of Public Administration.

Best Publications

  • Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.

    Ronny Drapkin;Hans Henning von Horsten;Yafang Lin;Samuel C. Mok

  • Dicer, Drosha, and outcomes in patients with ovarian cancer

    William M. Merritt;Yvonne G. Lin;Liz Y. Han;Aparna A. Kamat

  • Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.

    Toshiyasu Taniguchi;Marc Tischkowitz;Najim Ameziane;Shirley V. Hodgson

  • Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1.

    Chi Lam Au Yeung;Ngai Na Co;Tetsushi Tsuruga;Tsz Lun Yeung

  • Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer

    Jae Hoon Kim;Steven J. Skates;Toshimitsu Uede;Kwong Kwok Wong

  • Potential markers that complement expression of CA125 in epithelial ovarian cancer

    Daniel G. Rosen;Lin Wang;J. Neeley Atkinson;Yinhua Yu

  • CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks

    F Guo;Y Wang;J Liu;S C Mok

  • Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract.

    Alison J. Quayle;Edith Porter;Aimee A. Nussbaum;Yun Mei Wang

  • Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.

    Tsz Lun Yeung;Cecilia S. Leung;Cecilia S. Leung;Kay Pong Yip;Chi Lam Au Yeung

  • Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

    Tomas Bonome;Ji Young Lee;Dong Choon Park;Mike Radonovich

  • TGF-β Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment

    Tsz Lun Yeung;Cecilia S. Leung;Kwong Kwok Wong;Goli Samimi

  • Haptoglobin-α subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry

    Bin Ye;Daniel W. Cramer;Steven J. Skates;Steven P. Gygi

  • Prostasin, a Potential Serum Marker for Ovarian Cancer: Identification Through Microarray Technology

    Samuel C. Mok;Julie Chao;Steven Skates;Kwong Kwok Wong

  • Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth.

    Lifeng Yang;Abhinav Achreja;Tsz Lun Yeung;Lingegowda S. Mangala

  • BRCA1 Supports XIST RNA Concentration on the Inactive X Chromosome

    Shridar Ganesan;Daniel P. Silver;Roger A. Greenberg;Dror Avni

  • Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells

    Kin Mang Lau;Samuel C. Mok;Shuk Mei Ho;Shuk Mei Ho

  • Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells

    Viqar Syed;Gregory Ulinski;Samuel C. Mok;Gary K. Yiu

  • The biology of ovarian cancer

    N. Auersperg;M. I. Edelson;S. C. Mok;S. W. Johnson

  • A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2

    Samuel C. Mok;Tomas Bonome;Vinod Vathipadiekal;Aaron Bell

  • SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis in Ovarian Cancer Cells

    Gary K. Yiu;Wood Yee Chan;Shu Wing Ng;Pui Suen Chan

Frequent Co-Authors

Ross S. Berkowitz
Ross S. Berkowitz Harvard Medical School
Michael J. Birrer
Michael J. Birrer University of Arkansas for Medical Sciences
Karen H. Lu
Karen H. Lu The University of Texas MD Anderson Cancer Center
Daniel W. Cramer
Daniel W. Cramer Brigham and Women's Hospital
David M. Gershenson
David M. Gershenson The University of Texas MD Anderson Cancer Center
Anil K. Sood
Anil K. Sood The University of Texas MD Anderson Cancer Center
Stephen T. C. Wong
Stephen T. C. Wong Houston Methodist
Michael T. Deavers
Michael T. Deavers Houston Methodist
Jinsong Liu
Jinsong Liu The University of Texas MD Anderson Cancer Center
John N. Brady
John N. Brady National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t have to stop at becoming a doctor. There are many alternative healthcare roles accessible through online study. For those interested in pharmaceuticals, several pharmd online programs offer flexibility while targeting the growing pharmacy sector.

Information management is another vital healthcare field. Obtaining an him associate degree online can open doors to roles handling critical patient data, compliance, and digital record systems.

Medical administration is also in high demand. If you’re looking for entry-level positions, it’s essential to understand the average cost of medical billing and coding program and select accredited courses that provide strong employment prospects.

For nurses aiming for advanced roles, becoming a nurse practitioner can also be more affordable than you think, thanks to the cheapest np school online options.

These pathways offer diverse options for those passionate about healthcare, allowing for increased flexibility, varied career choices, and the potential to support patient care across many settings.

Best Scientists Citing Samuel C. Mok

Trending Scientists